Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. https://doi.org/10.3322/caac.21834.

Article  PubMed  Google Scholar 

Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global cancer observatory: cancer today (version 1.1). Lyon, France: International agency for research on cancer [Internet]. 2024 [cited 2025 Nov 1]. https://gco.iarc.who.int/today. Accessed 1 Nov 2025.

Filho AM, Laversanne M, Ferlay J, Colombet M, Piñeros M, Znaor A, et al. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156:1336–46. https://doi.org/10.1002/ijc.35278. (John Wiley and Sons Inc).

Article  CAS  PubMed  Google Scholar 

Bray F, Møller B. Predicting the future burden of cancer. Nat Rev Cancer. 2006;6:63–74. https://doi.org/10.1038/nrc1781.

Article  CAS  PubMed  Google Scholar 

Ferlay J, Laversanne M, Ervik M, Lam F, Colombet M, Mery L, et al. Global cancer observatory: cancer tomorrow (version 1.1). Lyon, France: International agency for research on cancer [Internet]. 2024 [cited 2025 Nov 1]. https://gco.iarc.who.int/tomorrow. Accessed 1 Nov 2025.

Li J, Kuang X. Global cancer statistics of young adults and its changes in the past decade: incidence and mortality from GLOBOCAN 2022. Public Health. 2024;237:336–43. https://doi.org/10.1016/j.puhe.2024.10.033.

Article  PubMed  Google Scholar 

Wu Z, Xia F, Lin R. Global burden of cancer and associated risk factors in 204 countries and territories, 1980–2021: a systematic analysis for the GBD 2021. J Hematol Oncol. 2024;17:119. https://doi.org/10.1186/s13045-024-01640-8.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Q, Yu H, Zhong J, Cheng W, Qi Y. Global, regional, and national burden of brain and central nervous system cancer: a systematic analysis of incidence, deaths, and DALYS with predictions to 2040. Int J Surg. 2025;111:4033–8. https://doi.org/10.1097/JS9.0000000000002359.

Article  PubMed  PubMed Central  Google Scholar 

Baskar R, Lee KA, Yeo R, Yeoh K-W. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9:193–9. https://doi.org/10.7150/ijms.3635.

Article  PubMed  PubMed Central  Google Scholar 

De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AWM, Hegi-Johnson F. Radiotherapy toxicity. Nat Rev Dis Primers. 2019;5:13. https://doi.org/10.1038/s41572-019-0064-5.

Article  PubMed  Google Scholar 

Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence‐based clinical guidelines. Cancer. 2005;104:1129–37. https://doi.org/10.1002/cncr.21324.

Article  PubMed  Google Scholar 

Lievens Y, Borras JM, Grau C. Provision and use of radiotherapy in Europe. Mol Oncol. 2020;14:1461–9. https://doi.org/10.1002/1878-0261.12690.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Si J, Gan L, Zhou R, Guo M, Zhang H. Harnessing the targeting potential of differential radiobiological effects of photon versus particle radiation for cancer treatment. J Cell Physiol. 2021;236:1695–711. https://doi.org/10.1002/jcp.29960.

Article  CAS  PubMed  Google Scholar 

Melia E, Parsons JL. DNA damage and repair dependencies of ionising radiation modalities. Biosci Rep. 2023;43:BSR20222586. https://doi.org/10.1042/BSR20222586.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baatout S, editor. Radiobiology Textbook [Internet]. Cham: Springer International Publishing; 2023 [cited 2025 Nov 1]. https://doi.org/10.1007/978-3-031-18810-7.

Chang DS, Lasley FD, Das IJ, Mendonca MS, Dynlacht JR. Basic Radiotherapy Physics and Biology [Internet]. Cham: Springer International Publishing; 2021 [cited 2025 Nov 1]. https://doi.org/10.1007/978-3-030-61899-5.

Nikitaki Z, Velalopoulou A, Zanni V, Tremi I, Havaki S, Kokkoris M, et al. Key biological mechanisms involved in high-LET radiation therapies with a focus on DNA damage and repair. Expert Rev Mol Med. 2022;24:e15. https://doi.org/10.1017/erm.2022.6.

Article  CAS  PubMed  Google Scholar 

Mladenova V, Mladenov E, Stuschke M, Iliakis G. DNA damage clustering after ionizing radiation and consequences in the processing of chromatin breaks. Molecules. 2022;27:1540. https://doi.org/10.3390/molecules27051540.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Bi K, Yang R, Li H, Nikitaki Z, Chang L. Role of DNA damage and repair in radiation cancer therapy: a current update and a look to the future. Int J Radiat Biol. 2020;96:1329–38. https://doi.org/10.1080/09553002.2020.1807641.

Article  CAS  PubMed  Google Scholar 

Huang R-X, Zhou P-K. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther. 2020;5:60. https://doi.org/10.1038/s41392-020-0150-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zong C, Zhu T, He J, Huang R, Jia R, Shen J. PARP mediated DNA damage response, genomic stability and immune responses. Int J Cancer. 2022;150:1745–59. https://doi.org/10.1002/ijc.33918.

Article  CAS  PubMed  Google Scholar 

Rose M, Burgess JT, O’Byrne K, Richard DJ, Bolderson E. PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance. Front Cell Dev Biol. 2020;8:564601. https://doi.org/10.3389/fcell.2020.564601.

Article  PubMed  PubMed Central  Google Scholar 

Morales J, Li L, Fattah FJ, Dong Y, Bey EA, Patel M, et al. Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. Crit Rev Eukaryot Gene Expr. 2014;24:15–28. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2013006875.

Article  PubMed  PubMed Central  Google Scholar 

Rivero Belenchón I, Congregado Ruiz CB, Saez C, Osman García I, Medina López RA. PARP inhibitors and radiotherapy: a new combination for prostate cancer (systematic review). Int J Mol Sci. 2023;24:12978. https://doi.org/10.3390/ijms241612978.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spiegel JO, Van Houten B, Durrant JD. PARP1: structural insights and pharmacological targets for inhibition. DNA Repair. 2021;103:103125. https://doi.org/10.1016/j.dnarep.2021.103125.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanev P-B, Atemin A, Stoynov S, Aleksandrov R. PARP1 roles in DNA repair and DNA replication: the basi(c)s of PARP inhibitor efficacy and resistance. Semin Oncol. 2024;51:2–18. https://doi.org/10.1053/j.seminoncol.2023.08.001.

Article  CAS  PubMed  Google Scholar 

Ray Chaudhuri A, Nussenzweig A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat Rev Mol Cell Biol. 2017;18:610–21. https://doi.org/10.1038/nrm.2017.53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Javle M, Curtin NJ. The role of PARP in DNA repair and its therapeutic exploitation. Br J Cancer. 2011;105:1114–22. https://doi.org/10.1038/bjc.2011.382.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen A. PARP inhibitors: its role in treatment of cancer. Chin J Cancer. 2011;463–71. https://doi.org/10.5732/cjc.011.10111.

Zhu H, Wei M, Xu J, Hua J, Liang C, Meng Q, et al. PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications. Mol Cancer. 2020;19:49. https://doi.org/10.1186/s12943-020-01167-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng F, Zhang Y, Chen S, Weng X, Rao Y, Fang H. Mechanism and current progress of poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer. Biomed Pharmacother. 2020;123:109661. https://doi.org/10.1016/j.biopha.2019.109661.

Article  CAS  PubMed